pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
VAROPHEN
VAROPHEN (DICLOFENAC SODIUM AND MENTHOL, METHYL SALICYLATE)
APOTEX
0 catalysts
VASERETIC
VASERETIC (ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE)
BAUSCH
0 catalysts
VASOPRESSIN IN 0.9% SODIUM CHLORIDE
VASOPRESSIN IN 0.9% SODIUM CHLORIDE (VASOPRESSIN IN 0.9% SODIUM CHLORIDE)
BAXTER HLTHCARE CORP
0 catalysts
Phase 1
VAX-014
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)
Vaxiion Therapeutics Inc
0 catalysts
← prev
page 145 of 231
next →
131
Pain89
Neurology1
Phase 2
VAX-24
Streptococcal Pneumonia
$PCVXVaxcyte, Inc.
0 catalysts
Phase 3
VAX-31
Streptococcal Pneumonia
$PCVXVaxcyte, Inc.
0 catalysts
Preclinical
VAXA-1
Streptococcal Infections
$PCVXVaxcyte, Inc.
0 catalysts
Preclinical
VB-0004
Kidney Fibrosis
Vectus Biosystems Ltd
0 catalysts
Preclinical
VB-001
Acute Ischemic Stroke
VST Bio Corp
0 catalysts
Phase 2
VB-1953
Acne Vulgaris
$HINDVyome Holdings, Inc
0 catalysts
Phase 2
VBC-103
Metastatic Transitional (Urothelial) Tract Cancer
Avenzo Therapeutics Inc
0 catalysts
Phase 2
VBI-1901
Recurrent Glioblastoma Multiforme (GBM)
VBI Vaccines Inc
0 catalysts
Preclinical
VBX-100
Irritable Bowel Syndrome
$RNGERANGE IMPACT, INC.
0 catalysts
Phase 2
VC-01
Type 1 Diabetes (Juvenile Diabetes)
$VERXVertex, Inc.
0 catalysts
Phase 2
VC-02
PEC-Direct
Type 1 Diabetes (Juvenile Diabetes)
ViaCyte, Inc.
0 catalysts
Phase 2
VCA-894A
Charcot-Marie-Tooth Disease Type II
$VNDAVanda Pharmaceuticals Inc.
0 catalysts
Phase 1
VCC-001
Renal Cell Carcinoma
Vaccentis AG
0 catalysts
Phase 2
VCT-220
Obesity
CORXEL Pharmaceuticals (Shanghai) Co Ltd
0 catalysts
Phase 3
VE-303
Clostridioides difficile Infections (Clostridium difficile Associated Disease)
Vedanta Biosciences Inc
0 catalysts
VENLAFAXINE
VENLAFAXINE (VENLAFAXINE)
ALKEM LABS LTD
0 catalysts
Preclinical
VERI-101
Solid Tumor
VerImmune Inc
0 catalysts
Preclinical
VERSAMAB-101
Acute Spinal Cord Injury
VersaPeutics Inc
0 catalysts
Phase 2
VG-161
Bile Duct Cancer (Cholangiocarcinoma)
Virogin Biotech Ltd
0 catalysts
Phase 1
VG-201
Colorectal Cancer
Virogin Biotech Ltd
0 catalysts
Phase 1
VG-203
Solid Tumor
Virogin Biotech Ltd
0 catalysts
Phase 2
VG-801
Unspecified Ophthalmological Disorders
VeonGen Therapeutics GmbH
0 catalysts
Preclinical
VH-310
Human Immunodeficiency Virus (HIV) Infections (AIDS)
ViiV Healthcare UK Ltd
0 catalysts
Phase 2
VH-4524184
Human Immunodeficiency Virus (HIV) Infections (AIDS)
ViiV Healthcare UK Ltd
0 catalysts
Phase 2
VIM-0423
Dystonia
Vima Therapeutics Inc
0 catalysts
Phase 1
VIPER-101
Anaplastic Large Cell Lymphoma (ALCL)
ViTToria Biotherapeutics Inc
0 catalysts